Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
SymbioCellTech, LLC
Develops stem cell-based Neo-Islet therapy to cure type 1 diabetes without immunosuppressive drugs.
SeedBiotechSalt Lake City, UT1-10 employees
Total raised
$5.0M
Last round
Equity
$286K · Aug 2017
Stage
Seed
Status
Active
Founders & team
Growth signals
Track SymbioCellTech, LLC on FlareSight
Get notified the moment SymbioCellTech, LLC files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.